The "D-dimer Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global D-dimer Testing Market to Reach $2.7 Billion by 2027

Amid the COVID-19 crisis, the global market for D-dimer Testing estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 3.8% over the period 2020-2027.

Point-of-Care Tests, one of the segments analyzed in the report, is projected to record 4% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laboratory Tests segment is readjusted to a revised 3.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $609 Million, While China is Forecast to Grow at 3.6% CAGR

The D-dimer Testing market in the U.S. is estimated at US$609 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$478.1 Million by the year 2027 trailing a CAGR of 3.6% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 38 Featured):

• Abbott Laboratories, Inc.
• Alere, Inc.
• Beckman Coulter, Inc.
• Becton, Dickinson and Company
• Bio/Data Corporation
• Corgenix
• F. Hoffmann-La Roche AG
• Helena Biosciences Europe
• Siemens Healthcare GmbH
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• Trinity Biotech PLC

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

• World 15-Year Perspective for Point-of-Care Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Laboratory Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Deep Vein Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Pulmonary Embolism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Disseminated Intravascular Coagulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
• World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 38

For more information about this report visit https://www.researchandmarkets.com/r/b76tdn

View source version on businesswire.com: https://www.businesswire.com/news/home/20210513005462/en/